Place of consensus type interferon alpha in the management of chronic type C hepatitis
Juszczyk, J.
Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 14(82): 275-278
2003
ISSN/ISBN: 1426-9686 PMID: 12868183 Document Number: 558895
This paper presents the results of clinical investigations of efficacy of consensus type interferon (Alfacon-1) in monotherapy, as well as in combination with ribavirin. A special indication for this kind of interferon are "difficult" patients with high virial load non-responders for previous treatment, as well as with recurrence of infection.
Document emailed within 1 workday
Related Documents
Perrillo, R.P.; Regenstein, F.G.; Peters, M.G.; DeSchryver-Kecskemeti, K.; Bodicky, C.J.; Campbell, C.R.; Kuhns, M.C. 1988: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial Annals of Internal Medicine 109(2): 95-100Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Inoue, O.; Yano, M. 1994: Long-term prognosis after interferon therapy in chronic hepatitis type C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1828-1831
Okano, J.; Horie, Y.; Kawasaki, H.; Kondo, M. 1997: Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C Hepato-Gastroenterology 44(14): 525-528
Ishibashi, K.; Kashiwagi, T.; Ito, A.; Tanaka, Y.; Nagata, T.; Tamaki, J.; Azuma, M.; Kishida, Y.; Yoshida, A.; Hikiji, A.Y. 1995: Predictive factors for efficacy of interferon therapy in chronic hepatitis type C Hepato-Gastroenterology 42(5): 535-541
Karray, S.; Delfraissy, J.F.; Merle-Beral, H.; Wallon, C.; Debre, P.; Galanaud, P. 1988: Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response Journal of Immunology 140(3): 774-778
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Loh, J.E.; Chang, C.H.; Fodor, W.L.; Flavell, R.A. 1992: Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s) EMBO Journal 11(4): 1351-1363
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Ghosal, S.; Sinha, B.; Majumder, A.; Das, A.Kumar.; Singh, A.Kumar.; Ghoshdastidar, B.; Maji, D.; Goyal, G.; Mukherjee, J.Jyoti.; Gangopadhyay, K.Kumar.; John, M.; Chatterjee, S.; Jaggi, S.; Ray, S.; Majumdar, S.; Sharma, S.Kumar. 2017: Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?" Journal of the Association of Physicians of India 65(7): 51-62
Swobodnik, W. 1995: Interferon-alpha in chronic hepatitis C Deutsche Medizinische Wochenschrift 120(34-35): 1186
Suzuki, H.; Sata, M.; Noguchi, S.; Uchimura, Y.; Tanikawa, K. 1996: Acute hepatitis type C co-infected with GBV-C treated with interferon American Journal of Gastroenterology 91(12): 2651-2652
Matei, I.; Tănăsescu, C.; Voiosu, R.; Murariu, E.; Dragomir, P.; Serbănescu, A. 1998: Treatment with alpha-interferon in chronic hepatitis Romanian Journal of Internal Medicine 36(3-4): 227-237
Zuberi, S.J.; Alam, S.E.; Raza, S. 1994: Interferon alpha 2a in patients of chronic hepatitis C Jpma. Journal of the Pakistan Medical Association 44(7): 171-172
Ward, A.B.; Wissel, Jörg.; Molteni, F.; Yakovleff, A.; Gedin, S.; Aguilar, M.; Kanovsky, P.; Zegers de Beyl, D. 2003: European consensus statement on the use of botulinum toxin type A in the management of adult spasticity Acta Neurologica Belgica 103(1): 39
Worman, H.J. 1995: Interferon-alpha is effective in the treatment of chronic hepatitis C American Journal of Gastroenterology 90(4): 679-680
Cinquetti, M.; Marchi, D. 1995: Alpha-interferon in the treatment of chronic hepatitis C in children La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 17(6): 501-507